Healthcare Global Enterprises Li (NSE: HCG) and PARK MEDI WORLD LIMITED (NSE: PARKHOSPS) are both listed in the Hospitals and Healthcare Centers industry. Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr and PARK MEDI WORLD ₹9,670 Cr, as of 9 Nov 2026. Their P/E ratios are 611.3 and 34.5 respectively. Return on equity is 1.90% for Healthcare Global Enterprises Li and 13.00% for PARK MEDI WORLD.
| Metric | Healthcare Global Enterprises Li | PARK MEDI WORLD |
|---|---|---|
| NSE Symbol | HCG | PARKHOSPS |
| BSE Code | 539787 | 544645 |
| Share Price | ₹587.10 | ₹267.40 |
| Market Cap | ₹8,761 Cr | ₹9,670 Cr |
| P/E Ratio | 611.3 | 34.5 |
| Return on Equity | 1.90% | 13.00% |
| Return on Assets | 3.81% | 9.66% |
| Beta (1Y) | 0.35 | 0.93 |
| 1-Year Price Change | -22.0% | — |
| 3-Month Price Change | -18.0% | -7.5% |
| 52-Week Range | ₹513.30 – ₹775.00 | ₹138.10 – ₹305.00 |
| Latest Quarter | Q2 FY27 | Q1 FY27 |
| Quarterly Revenue | ₹732 Cr | ₹476 Cr |
| Quarterly Net Profit | ₹9 Cr | ₹89 Cr |
| Net Margin | 1.3% | 18.6% |
| EPS (Basic, Quarter) | ₹0.32 | ₹2.05 |
| Results Basis | consolidated | consolidated |
| Headquarters | Bengaluru, Karnataka | Gurugram, Haryana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marro…
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumat…
PARK MEDI WORLD has a market capitalisation of ₹9,670 Cr, against ₹8,761 Cr for Healthcare Global Enterprises Li as of 9 Nov 2026, about 1.1 times the size by market cap.
Healthcare Global Enterprises Li has a P/E of 611.3 and PARK MEDI WORLD a P/E of 34.5 as of 9 Nov 2026.
Healthcare Global Enterprises Li has a return on equity of 1.90% and PARK MEDI WORLD 13.00%.
Healthcare Global Enterprises Li reported revenue of ₹732 Cr and net profit of ₹9 Cr for Q2 FY27. PARK MEDI WORLD reported revenue of ₹476 Cr and net profit of ₹89 Cr for Q1 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.